IKT · Categories · Form 4

IKT - SEC Form 4 insider transactions

Inhibikase Therapeutics Inc. (IKT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for IKT

• 61d
  Director Aurentz Vincent returned 255,299 shares to the company, decreasing direct ownership by 33% to 510,596 units (SEC Form 4)

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 61d
  President & Head of R&D Cabell Christopher returned 338,282 shares to the company, decreasing direct ownership by 33% to 676,564 units (SEC Form 4)

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 61d
  Director Munshi Amit returned 19,089 shares to the company, decreasing direct ownership by 33% to 38,176 units (SEC Form 4)

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 109d
  SEC Form 4 filed by Chief Executive Officer Iwicki Mark T

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 109d
  SEC Form 4 filed by President & Head of R&D Cabell Christopher

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 109d
  SEC Form 4 filed by Chief Financial Officer Mcintyre David

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 241d
  Director Munshi Amit was granted 57,265 shares (SEC Form 4)

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 298d
  Amendment: SEC Form 4 filed by President & Head of R&D Cabell Christopher

  4/A - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 298d
  Amendment: SEC Form 4 filed by Chief Executive Officer Iwicki Mark T

  4/A - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 298d
  Amendment: SEC Form 4 filed by Director Aurentz Vincent

  4/A - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 298d
  SEC Form 4 filed by Director Aurentz Vincent

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 298d
  SEC Form 4 filed by Director Canner David

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 298d
  SEC Form 4 filed by Director Munshi Amit

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 298d
  SEC Form 4 filed by Director Kush Arvind

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 298d
  SEC Form 4 filed by Director Berman Dennis N

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 298d
  SEC Form 4 filed by Director Bellini Roberto

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 375d
  SEC Form 4 filed by Chief Financial Officer Mcintyre David

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 425d
  SEC Form 4 filed by President & Head of R&D Cabell Christopher

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 425d
  SEC Form 4 filed by Director Aurentz Vincent

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 425d
  SEC Form 4 filed by Chief Executive Officer Iwicki Mark T

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 431d
  SEC Form 4 filed by Chief Executive Officer Iwicki Mark T

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 431d
  SEC Form 4 filed by Director Kush Arvind

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 431d
  SEC Form 4 filed by Director Bellini Roberto

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 431d
  SEC Form 4 filed by Director Freeman Roy Lester

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 431d
  SEC Form 4 filed by Director Munshi Amit

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 431d
  SEC Form 4 filed by Director Canner David

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 431d
  Amendment: SEC Form 4 filed by Director Berman Dennis N

  4/A - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 431d
  SEC Form 4 filed by Director Berman Dennis N

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 459d
  SEC Form 4 filed by Director Berman Dennis N

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 459d
  SEC Form 4 filed by Director Freeman Roy Lester

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 459d
  SEC Form 4 filed by President and CEO Werner Milton H.

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 459d
  SEC Form 4 filed by Chief Financial Officer Lees-Rolfe Garth

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 474d
  SEC Form 4 filed by President and CEO Werner Milton H.

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 474d
  SEC Form 4 filed by Chief Financial Officer Lees-Rolfe Garth

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 474d
  SEC Form 4 filed by Director Freeman Roy Lester

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 474d
  SEC Form 4 filed by Director Berman Dennis N

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 550d
  SEC Form 4 filed by Director Canner David

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 647d
  SEC Form 4 filed by Director Grint Paul C

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 647d
  SEC Form 4 filed by Director Dion Gisele

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 647d
  SEC Form 4 filed by Director Berman Dennis N

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 647d
  SEC Form 4 filed by Director Freeman Roy Lester

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 753d
  SEC Form 4 filed by Werner Milton H.

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 754d
  SEC Form 4 filed by Lees-Rolfe Garth

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1026d
  SEC Form 4 filed by Berman Dennis N

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1026d
  SEC Form 4 filed by Dion Gisele

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1026d
  SEC Form 4 filed by Grint Paul C

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1026d
  SEC Form 4 filed by Freeman Roy Lester

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1328d
  SEC Form 4 filed by Dion Gisele

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1349d
  SEC Form 4: Werner Milton H. bought $4,000 worth of shares (5,000 units at $0.80), increasing direct ownership by 0.09% to 5,335,433 units

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1398d
  SEC Form 4 filed by Grint Paul C

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1398d
  SEC Form 4 filed by Freeman Roy Lester

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1398d
  SEC Form 4 filed by Berman Dennis N

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1398d
  SEC Form 4 filed by O'Farrell Elizabeth G.

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1427d
  SEC Form 4: Werner Milton H. bought $4,880 worth of shares (5,000 units at $0.98), increasing direct ownership by 0.09% to 5,330,433 units

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1434d
  SEC Form 4: Werner Milton H. bought $6,000 worth of shares (10,000 units at $0.60), increasing direct ownership by 0.19% to 5,325,433 units

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1434d
  SEC Form 4: Frattaroli Joseph bought $2,543 worth of shares (3,948 units at $0.64), increasing direct ownership by 9% to 48,091 units

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1497d
  SEC Form 4 filed by Frattaroli Joseph

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1497d
  SEC Form 4 filed by Werner Milton H.

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1509d
  SEC Form 4 filed by Frattaroli Joseph

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)
• 1509d
  SEC Form 4 filed by Werner Milton H.

  4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)

Other IKT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends